The global Non- Alcoholic Steatohepatitis Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Non- Alcoholic Steatohepatitis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Non- Alcoholic Steatohepatitis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non- Alcoholic Steatohepatitis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non- Alcoholic Steatohepatitis Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Non- Alcoholic Steatohepatitis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Non- Alcoholic Steatohepatitis Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Non- Alcoholic Steatohepatitis Treatment Market Report

Report Metric	Details
Report Name	Non- Alcoholic Steatohepatitis Treatment Market
CAGR	5%
Segment by Type	Cenicriviroc Aramchol Resmetirom Semaglutide Lanifibranor Obeticholic Acid (OCA)
Segment by Application	Retail & Specialty Pharmacies Hospital Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gilead Sciences, Bristol Myers Squibb, Novo Nordisk, NGM Biopharmaceuticals, Galectin Therapeutics, Inventiva Pharma, Intercept Pharmaceuticals, AbbVie, Madrigal Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Non- Alcoholic Steatohepatitis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non- Alcoholic Steatohepatitis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non- Alcoholic Steatohepatitis Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Non- Alcoholic Steatohepatitis Treatment Market report?

Ans: The main players in the Non- Alcoholic Steatohepatitis Treatment Market are Gilead Sciences, Bristol Myers Squibb, Novo Nordisk, NGM Biopharmaceuticals, Galectin Therapeutics, Inventiva Pharma, Intercept Pharmaceuticals, AbbVie, Madrigal Pharmaceuticals

What are the Application segmentation covered in the Non- Alcoholic Steatohepatitis Treatment Market report?

Ans: The Applications covered in the Non- Alcoholic Steatohepatitis Treatment Market report are Retail & Specialty Pharmacies, Hospital Pharmacies, Others

What are the Type segmentation covered in the Non- Alcoholic Steatohepatitis Treatment Market report?

Ans: The Types covered in the Non- Alcoholic Steatohepatitis Treatment Market report are Cenicriviroc, Aramchol, Resmetirom, Semaglutide, Lanifibranor, Obeticholic Acid (OCA)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Cenicriviroc

1.2.3 Aramchol

1.2.4 Resmetirom

1.2.5 Semaglutide

1.2.6 Lanifibranor

1.2.7 Obeticholic Acid (OCA)

1.3 Market by Application

1.3.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Retail & Specialty Pharmacies

1.3.3 Hospital Pharmacies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non- Alcoholic Steatohepatitis Treatment Market Perspective (2019-2030)

2.2 Global Non- Alcoholic Steatohepatitis Treatment Growth Trends by Region

2.2.1 Non- Alcoholic Steatohepatitis Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non- Alcoholic Steatohepatitis Treatment Historic Market Size by Region (2019-2024)

2.2.3 Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2025-2030)

2.3 Non- Alcoholic Steatohepatitis Treatment Market Dynamics

2.3.1 Non- Alcoholic Steatohepatitis Treatment Industry Trends

2.3.2 Non- Alcoholic Steatohepatitis Treatment Market Drivers

2.3.3 Non- Alcoholic Steatohepatitis Treatment Market Challenges

2.3.4 Non- Alcoholic Steatohepatitis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Non- Alcoholic Steatohepatitis Treatment by Players

3.1.1 Global Non- Alcoholic Steatohepatitis Treatment Revenue by Players (2019-2024)

3.1.2 Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Non- Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Non- Alcoholic Steatohepatitis Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Non- Alcoholic Steatohepatitis Treatment Market Concentration Ratio

3.4.1 Global Non- Alcoholic Steatohepatitis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non- Alcoholic Steatohepatitis Treatment Revenue in 2023

3.5 Global Key Players of Non- Alcoholic Steatohepatitis Treatment Head office and Area Served

3.6 Global Key Players of Non- Alcoholic Steatohepatitis Treatment, Product and Application

3.7 Global Key Players of Non- Alcoholic Steatohepatitis Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non- Alcoholic Steatohepatitis Treatment Breakdown Data by Type

4.1 Global Non- Alcoholic Steatohepatitis Treatment Historic Market Size by Type (2019-2024)

4.2 Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2025-2030)

5 Non- Alcoholic Steatohepatitis Treatment Breakdown Data by Application

5.1 Global Non- Alcoholic Steatohepatitis Treatment Historic Market Size by Application (2019-2024)

5.2 Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non- Alcoholic Steatohepatitis Treatment Market Size (2019-2030)

6.2 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Type

6.2.1 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024)

6.2.2 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2025-2030)

6.2.3 North America Non- Alcoholic Steatohepatitis Treatment Market Share by Type (2019-2030)

6.3 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Application

6.3.1 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024)

6.3.2 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2025-2030)

6.3.3 North America Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2030)

6.4 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country

6.4.1 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024)

6.4.3 North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Non- Alcoholic Steatohepatitis Treatment Market Size (2019-2030)

7.2 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Type

7.2.1 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024)

7.2.2 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2025-2030)

7.2.3 Europe Non- Alcoholic Steatohepatitis Treatment Market Share by Type (2019-2030)

7.3 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Application

7.3.1 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024)

7.3.2 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2025-2030)

7.3.3 Europe Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2030)

7.4 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country

7.4.1 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024)

7.4.3 Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Non- Alcoholic Steatohepatitis Treatment Market Size (2019-2030)

8.2 China Non- Alcoholic Steatohepatitis Treatment Market Size by Type

8.2.1 China Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024)

8.2.2 China Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2025-2030)

8.2.3 China Non- Alcoholic Steatohepatitis Treatment Market Share by Type (2019-2030)

8.3 China Non- Alcoholic Steatohepatitis Treatment Market Size by Application

8.3.1 China Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024)

8.3.2 China Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2025-2030)

8.3.3 China Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Non- Alcoholic Steatohepatitis Treatment Market Size (2019-2030)

9.2 Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Type

9.2.1 Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024)

9.2.2 Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2025-2030)

9.2.3 Asia Non- Alcoholic Steatohepatitis Treatment Market Share by Type (2019-2030)

9.3 Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Application

9.3.1 Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024)

9.3.2 Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2025-2030)

9.3.3 Asia Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2030)

9.4 Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Region

9.4.1 Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2019-2024)

9.4.3 Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Gilead Sciences

11.1.1 Gilead Sciences Company Details

11.1.2 Gilead Sciences Business Overview

11.1.3 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Introduction

11.1.4 Gilead Sciences Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

11.1.5 Gilead Sciences Recent Developments

11.2 Bristol Myers Squibb

11.2.1 Bristol Myers Squibb Company Details

11.2.2 Bristol Myers Squibb Business Overview

11.2.3 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Introduction

11.2.4 Bristol Myers Squibb Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

11.2.5 Bristol Myers Squibb Recent Developments

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Details

11.3.2 Novo Nordisk Business Overview

11.3.3 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Introduction

11.3.4 Novo Nordisk Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

11.3.5 Novo Nordisk Recent Developments

11.4 NGM Biopharmaceuticals

11.4.1 NGM Biopharmaceuticals Company Details

11.4.2 NGM Biopharmaceuticals Business Overview

11.4.3 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Introduction

11.4.4 NGM Biopharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

11.4.5 NGM Biopharmaceuticals Recent Developments

11.5 Galectin Therapeutics

11.5.1 Galectin Therapeutics Company Details

11.5.2 Galectin Therapeutics Business Overview

11.5.3 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Introduction

11.5.4 Galectin Therapeutics Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

11.5.5 Galectin Therapeutics Recent Developments

11.6 Inventiva Pharma

11.6.1 Inventiva Pharma Company Details

11.6.2 Inventiva Pharma Business Overview

11.6.3 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Introduction

11.6.4 Inventiva Pharma Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

11.6.5 Inventiva Pharma Recent Developments

11.7 Intercept Pharmaceuticals

11.7.1 Intercept Pharmaceuticals Company Details

11.7.2 Intercept Pharmaceuticals Business Overview

11.7.3 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Introduction

11.7.4 Intercept Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

11.7.5 Intercept Pharmaceuticals Recent Developments

11.8 AbbVie

11.8.1 AbbVie Company Details

11.8.2 AbbVie Business Overview

11.8.3 AbbVie Non- Alcoholic Steatohepatitis Treatment Introduction

11.8.4 AbbVie Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

11.8.5 AbbVie Recent Developments

11.9 Madrigal Pharmaceuticals

11.9.1 Madrigal Pharmaceuticals Company Details

11.9.2 Madrigal Pharmaceuticals Business Overview

11.9.3 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Introduction

11.9.4 Madrigal Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

11.9.5 Madrigal Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Madrigal Pharmaceuticals

NGM Biopharmaceuticals

Galectin Therapeutics

Intercept Pharmaceuticals

AbbVie

List of Tables

Table 1. Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Cenicriviroc

Table 3. Key Players of Aramchol

Table 4. Key Players of Resmetirom

Table 5. Key Players of Semaglutide

Table 6. Key Players of Lanifibranor

Table 7. Key Players of Obeticholic Acid (OCA)

Table 8. Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 9. Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Region (2019-2024)

Table 12. Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Region (2025-2030)

Table 14. Non- Alcoholic Steatohepatitis Treatment Market Trends

Table 15. Non- Alcoholic Steatohepatitis Treatment Market Drivers

Table 16. Non- Alcoholic Steatohepatitis Treatment Market Challenges

Table 17. Non- Alcoholic Steatohepatitis Treatment Market Restraints

Table 18. Global Non- Alcoholic Steatohepatitis Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Non- Alcoholic Steatohepatitis Treatment Revenue Share by Players (2019-2024)

Table 20. Global Top Non- Alcoholic Steatohepatitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non- Alcoholic Steatohepatitis Treatment as of 2023)

Table 21. Global Non- Alcoholic Steatohepatitis Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 22. Global 5 Largest Players Market Share by Non- Alcoholic Steatohepatitis Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 23. Global Key Players of Non- Alcoholic Steatohepatitis Treatment, Headquarters and Area Served

Table 24. Global Key Players of Non- Alcoholic Steatohepatitis Treatment, Product and Application

Table 25. Global Key Players of Non- Alcoholic Steatohepatitis Treatment, Product and Application

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2019-2024)

Table 29. Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2025-2030)

Table 31. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Non- Alcoholic Steatohepatitis Treatment Revenue Share by Application (2019-2024)

Table 33. Global Non- Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Non- Alcoholic Steatohepatitis Treatment Revenue Share by Application (2025-2030)

Table 35. North America Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 36. North America Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 37. North America Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 38. North America Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 39. North America Non- Alcoholic Steatohepatitis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 41. North America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 42. Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 43. Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 44. Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 45. Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 46. Europe Non- Alcoholic Steatohepatitis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 48. Europe Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 49. China Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 50. China Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 51. China Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 52. China Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 54. Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 55. Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 56. Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 57. Asia Non- Alcoholic Steatohepatitis Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 58. Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 59. Asia Non- Alcoholic Steatohepatitis Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 65. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 67. Gilead Sciences Company Details

Table 68. Gilead Sciences Business Overview

Table 69. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Product

Table 70. Gilead Sciences Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)

Table 71. Gilead Sciences Recent Developments

Table 72. Bristol Myers Squibb Company Details

Table 73. Bristol Myers Squibb Business Overview

Table 74. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Product

Table 75. Bristol Myers Squibb Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)

Table 76. Bristol Myers Squibb Recent Developments

Table 77. Novo Nordisk Company Details

Table 78. Novo Nordisk Business Overview

Table 79. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Product

Table 80. Novo Nordisk Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)

Table 81. Novo Nordisk Recent Developments

Table 82. NGM Biopharmaceuticals Company Details

Table 83. NGM Biopharmaceuticals Business Overview

Table 84. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product

Table 85. NGM Biopharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)

Table 86. NGM Biopharmaceuticals Recent Developments

Table 87. Galectin Therapeutics Company Details

Table 88. Galectin Therapeutics Business Overview

Table 89. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Product

Table 90. Galectin Therapeutics Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)

Table 91. Galectin Therapeutics Recent Developments

Table 92. Inventiva Pharma Company Details

Table 93. Inventiva Pharma Business Overview

Table 94. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Product

Table 95. Inventiva Pharma Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)

Table 96. Inventiva Pharma Recent Developments

Table 97. Intercept Pharmaceuticals Company Details

Table 98. Intercept Pharmaceuticals Business Overview

Table 99. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product

Table 100. Intercept Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)

Table 101. Intercept Pharmaceuticals Recent Developments

Table 102. AbbVie Company Details

Table 103. AbbVie Business Overview

Table 104. AbbVie Non- Alcoholic Steatohepatitis Treatment Product

Table 105. AbbVie Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)

Table 106. AbbVie Recent Developments

Table 107. Madrigal Pharmaceuticals Company Details

Table 108. Madrigal Pharmaceuticals Business Overview

Table 109. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product

Table 110. Madrigal Pharmaceuticals Revenue in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024) & (US$ Million)

Table 111. Madrigal Pharmaceuticals Recent Developments

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Type: 2023 VS 2030

Figure 3. Cenicriviroc Features

Figure 4. Aramchol Features

Figure 5. Resmetirom Features

Figure 6. Semaglutide Features

Figure 7. Lanifibranor Features

Figure 8. Obeticholic Acid (OCA) Features

Figure 9. Global Non- Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application: 2023 VS 2030

Figure 11. Retail & Specialty Pharmacies Case Studies

Figure 12. Hospital Pharmacies Case Studies

Figure 13. Others Case Studies

Figure 14. Non- Alcoholic Steatohepatitis Treatment Report Years Considered

Figure 15. Global Non- Alcoholic Steatohepatitis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Non- Alcoholic Steatohepatitis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Players in 2023

Figure 19. Global Top Non- Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non- Alcoholic Steatohepatitis Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Non- Alcoholic Steatohepatitis Treatment Revenue in 2023

Figure 21. North America Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Non- Alcoholic Steatohepatitis Treatment Market Share by Type (2019-2030)

Figure 23. North America Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2030)

Figure 24. North America Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2019-2030)

Figure 25. United States Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Non- Alcoholic Steatohepatitis Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 28. Europe Non- Alcoholic Steatohepatitis Treatment Market Share by Type (2019-2030)

Figure 29. Europe Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2030)

Figure 30. Europe Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2019-2030)

Figure 31. Germany Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. China Non- Alcoholic Steatohepatitis Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 38. China Non- Alcoholic Steatohepatitis Treatment Market Share by Type (2019-2030)

Figure 39. China Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2030)

Figure 40. Asia Non- Alcoholic Steatohepatitis Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 41. Asia Non- Alcoholic Steatohepatitis Treatment Market Share by Type (2019-2030)

Figure 42. Asia Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2030)

Figure 43. Asia Non- Alcoholic Steatohepatitis Treatment Market Share by Region (2019-2030)

Figure 44. Japan Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. South Korea Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. China Taiwan Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. India Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Australia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Share by Type (2019-2030)

Figure 52. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2030)

Figure 53. Middle East, Africa, and Latin America Non- Alcoholic Steatohepatitis Treatment Market Share by Country (2019-2030)

Figure 54. Brazil Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Mexico Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Turkey Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Israel Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GCC Countries Non- Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Gilead Sciences Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

Figure 61. Bristol Myers Squibb Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

Figure 62. Novo Nordisk Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

Figure 63. NGM Biopharmaceuticals Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

Figure 64. Galectin Therapeutics Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

Figure 65. Inventiva Pharma Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

Figure 66. Intercept Pharmaceuticals Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

Figure 67. AbbVie Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

Figure 68. Madrigal Pharmaceuticals Revenue Growth Rate in Non- Alcoholic Steatohepatitis Treatment Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-33C941

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Primary Biliary Cholangitis Therapeutics Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-11W14373

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Combined Polio Vaccine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12Q18734

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Amebiasis Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-38D9688

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Non- Alcoholic Steatohepatitis Treatment Market Insights, Forecast to 2030

Published Date: November 2024

Report Code: QYRE-Auto-19S13424

Global Non- Alcoholic Steatohepatitis Treatment Market Insights, Forecast to 2030

FEATURED COMPANIES

Non- Alcoholic Steatohepatitis Treatment Market Size

Non- Alcoholic Steatohepatitis Treatment Market

Scope of Non- Alcoholic Steatohepatitis Treatment Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Non- Alcoholic Steatohepatitis Treatment Market report?

What are the Application segmentation covered in the Non- Alcoholic Steatohepatitis Treatment Market report?

What are the Type segmentation covered in the Non- Alcoholic Steatohepatitis Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS